CareLit · DOI-Nachweis · Aktuelle Neurologie
The role of MEIS1, BTBD9 and MAP2K5/LBXCOR1 in uraemic RLS – a case-control study in patients with end stage renal disease on maintenance hemodialysis
DOI 10.1055/s-0028-1086645
Bibliografische Angaben
Nachweis in CareLit
Autor:innenJ Plag, B Schormair, W Samtleben, B Müller-Myhsok, T Illig, T Meitinger, J Winkelmann
ZeitschriftAktuelle Neurologie
Ausgabe09/2008
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: An association between idiopathic Restless legs syndrome (iRLS) and intronic and intergenic variants in MEIS1 (Chromosome 2), BTBD9 (Chromosome 9) and MAP2K5/LBXCOR1 (Chromosome 15) was recently shown. RLS is a common complaint of patients with end-stage renal disease (ESRD), but the etiology of uraemic RLS (uRLS) is still unknown. Our aim was to investigate whether these genetic variants play also a r…
Zitieren
Zitierempfehlung
J Plag, B Schormair, W Samtleben, B Müller-Myhsok, T Illig, T Meitinger, J Winkelmann (2008) The role of MEIS1, BTBD9 and MAP2K5/LBXCOR1 in uraemic RLS – a case-control study in patients with end stage renal disease on maintenance hemodialysis. Aktuelle Neurologie (09). https://doi.org/10.1055/s-0028-1086645
Mit CareLit weiterarbeiten